Thrombolysis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 102354 Experts worldwide ranked by ideXlab platform

Heinrich J Audebert - One of the best experts on this subject based on the ideXlab platform.

  • comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers the telemedical pilot project for integrative stroke care in bavaria germany
    Stroke, 2006
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, Berthold Gotzler, J Schenkel, Stephan Hofer, A Furst, R L Haberl
    Abstract:

    Background and Purpose— Systemic Thrombolysis is the only therapy proven to be effective for ischemic stroke. Telemedicine may help to extend its use. However, concerns remain whether management and safety of tissue plasminogen activator (tPA) administration after telemedical consultation are equivalent in less experienced hospitals compared with tPA administration in academic stroke centers. Methods— During the second year of the ongoing Telemedical Pilot Project for Integrative Stroke Care, all systemic thrombolyses in stroke patients of the 12 regional clinics and the 2 stroke centers were recorded prospectively. Patients’ demographics, stroke severity (National Institutes of Health Stroke Scale), frequency of administration, time management, protocol violations, and safety were included in the analysis. Results— In 2004, 115 of 4727 stroke or transient ischemic attack patients (2.4%) in the community hospitals and 110 of 1889 patients in the stroke centers (5.8%) received systemic Thrombolysis. Prehos...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Stephan Clarmann Von Claranau, Johannes Kuhn, Guntram W Ickenstein, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Johannes Kuhn, Guntram W Ickenstein, Stephan Clarmann Von Claranau, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

R L Haberl - One of the best experts on this subject based on the ideXlab platform.

  • comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers the telemedical pilot project for integrative stroke care in bavaria germany
    Stroke, 2006
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, Berthold Gotzler, J Schenkel, Stephan Hofer, A Furst, R L Haberl
    Abstract:

    Background and Purpose— Systemic Thrombolysis is the only therapy proven to be effective for ischemic stroke. Telemedicine may help to extend its use. However, concerns remain whether management and safety of tissue plasminogen activator (tPA) administration after telemedical consultation are equivalent in less experienced hospitals compared with tPA administration in academic stroke centers. Methods— During the second year of the ongoing Telemedical Pilot Project for Integrative Stroke Care, all systemic thrombolyses in stroke patients of the 12 regional clinics and the 2 stroke centers were recorded prospectively. Patients’ demographics, stroke severity (National Institutes of Health Stroke Scale), frequency of administration, time management, protocol violations, and safety were included in the analysis. Results— In 2004, 115 of 4727 stroke or transient ischemic attack patients (2.4%) in the community hospitals and 110 of 1889 patients in the stroke centers (5.8%) received systemic Thrombolysis. Prehos...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Stephan Clarmann Von Claranau, Johannes Kuhn, Guntram W Ickenstein, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Johannes Kuhn, Guntram W Ickenstein, Stephan Clarmann Von Claranau, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

Markus Horn - One of the best experts on this subject based on the ideXlab platform.

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Stephan Clarmann Von Claranau, Johannes Kuhn, Guntram W Ickenstein, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Johannes Kuhn, Guntram W Ickenstein, Stephan Clarmann Von Claranau, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

Nils Kucher - One of the best experts on this subject based on the ideXlab platform.

  • ultrasound assisted Thrombolysis for acute pulmonary embolism a systematic review
    European Heart Journal, 2014
    Co-Authors: Rolf P Engelberger, Nils Kucher
    Abstract:

    Pulmonary embolism remains a common and potentially life-threatening disease. For patients with intermediate- and high-risk pulmonary embolism, catheter-based revascularization therapy has emerged as potential alternative to systemic Thrombolysis or surgical embolectomy. Ultrasound-assisted catheter-directed Thrombolysis is a contemporary catheter-based technique and is the focus of the present review. Ultrasound-assisted catheter-directed Thrombolysis is more effective in reversing right ventricular dysfunction and dilatation in comparison with anticoagulation alone in patients at intermediate risk. However, a direct comparison of ultrasound-assisted Thrombolysis with systemic Thrombolysis or surgical thrombectomy is not available. Ultrasound-assisted Thrombolysis with initial intrapulmonary thrombolytic bolus may also be effective in high-risk patients, but evidence from randomized trials is not available. This review summarizes current data on ultrasound-assisted Thrombolysis for acute pulmonary embolism.

C Kukla - One of the best experts on this subject based on the ideXlab platform.

  • comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers the telemedical pilot project for integrative stroke care in bavaria germany
    Stroke, 2006
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, Berthold Gotzler, J Schenkel, Stephan Hofer, A Furst, R L Haberl
    Abstract:

    Background and Purpose— Systemic Thrombolysis is the only therapy proven to be effective for ischemic stroke. Telemedicine may help to extend its use. However, concerns remain whether management and safety of tissue plasminogen activator (tPA) administration after telemedical consultation are equivalent in less experienced hospitals compared with tPA administration in academic stroke centers. Methods— During the second year of the ongoing Telemedical Pilot Project for Integrative Stroke Care, all systemic thrombolyses in stroke patients of the 12 regional clinics and the 2 stroke centers were recorded prospectively. Patients’ demographics, stroke severity (National Institutes of Health Stroke Scale), frequency of administration, time management, protocol violations, and safety were included in the analysis. Results— In 2004, 115 of 4727 stroke or transient ischemic attack patients (2.4%) in the community hospitals and 110 of 1889 patients in the stroke centers (5.8%) received systemic Thrombolysis. Prehos...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Stephan Clarmann Von Claranau, Johannes Kuhn, Guntram W Ickenstein, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...

  • telemedicine for safe and extended use of Thrombolysis in stroke the telemedic pilot project for integrative stroke care tempis in bavaria
    Stroke, 2005
    Co-Authors: Heinrich J Audebert, C Kukla, Bijan Vatankhah, J Schenkel, R L Haberl, Johannes Kuhn, Guntram W Ickenstein, Stephan Clarmann Von Claranau, Markus Horn
    Abstract:

    Background and Purpose— Systemic Thrombolysis represents the only proven therapy for acute ischemic stroke, but safe treatment is reported only in established stroke units. One major goal of the ongoing Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria is to extend the use of tissue plasminogen activator (tPA) treatment in nonurban areas through telemedic support. Methods— The stroke centers in Munich-Harlaching and in Regensburg established a telestroke network to provide consultations for 12 local hospitals in eastern Bavaria. The telemedic system consists of a digital network that includes a 2-way video conference system and CT/MRI image transfer with a high-speed data transmission up to 2 Mb/s. Each network hospital established specialized stroke wards in which qualified teams treat acute stroke patients. Physicians in these hospitals are able to contact the stroke centers 24 hours per day. Results— A total of 106 systemic thrombolyses were indicated via teleconsultations between...